

Bio
I am a skilled software engineer with expertise in web development, backend engineering, and application modernization. My focus is on delivering clean, scalable solutions by leveraging design patterns and object-oriented programming.
Away from development, I enjoy outdoor activities such as climbing, hiking, and whitewater. I bring the same problem-solving mindset to my adventures as I do to my work. Scroll down to see some photos from my adventures.

Professional Experience
Software Engineer I at Travel + Leisure, specializing in C# development for a .NET framework application. Skilled in maintaining and enhancing both WebForms and MVC pages, with experience in converting legacy codebases to MVC architecture. Developed a proof of concept (PoC) for migrating the frontend to React, demonstrating a forward-thinking approach to modernizing applications. Currently focused on sustainment efforts, including bug fixes, implementing new features, and optimizing stored procedures. Proficient in working with Active Record as an ORM to ensure efficient database interactions. Passionate about delivering scalable, maintainable solutions that drive business success.

An illustration depicting a peptide bound to an HLA molecule, highlighting the protein sequence within the peptide binding groove.
Peptide Binders Project
The Peptide Binders project is designed to support immunology researchers by providing an efficient tool for identifying and evaluating immunodominant peptides that bind to HLA molecules. It addresses the time-consuming and labor-intensive process of analyzing these interactions, which are critical for advancing research in autoimmune diseases, vaccine development, cancer immunology, and infectious disease control.
By enhancing data usability and visualization, the project empowers researchers to derive actionable insights more effectively. Its features—interactive graphs, real-time data streams, and saved searches—streamline workflows, reduce research time, and enhance the ability to analyze immune functions, driving progress in therapeutic development.